Microbio Group

Microbio Group, one of the largest biotech groups in Taiwan, is dedicated to research and development in innovative new drugs for oncology, immunology and unmet medical needs. The business scope covered by the companies and subsidiaries is dynamic, including health care, venture capital and organic retail channel. With a total investment of more than USD$750 million in the pipeline, Microbio focuses on developing first-in-class or best-in-class new drugs in botanical extracts, NCE, antibody, glycan molecule, aptamers and cell therapy. At Microbio, we have established platforms for post-biotics in-house fermentation, anti-body and aptamer development technology, equipping the Group with the capability...

New drug research and development in oncology,immunology,and unmet medical need.

Microbio group operates in the Biotechnology research industry.

Microbio group's revenue is 11m - 100m

Microbio group has 11 - 50 employees.